DLA Piper has advised Resmed. Wilson Sonsini Goodrich & Rosati has advised Noctrix Health. Resmed has completed the acquisition of Noctrix Health, Inc. for $340 million,...
Resmed Acquires Noctrix Health for $340 Million to Expand Sleep Health Portfolio
ABL Bio Announces Equity Investment Agreement with Lilly
Wilson Sonsini Goodrich & Rosati has advised ABL Bio. ABL Bio has announced the signing of an equity investment agreement valued at KRW 22 billion with...
Brookfield’s $1 Billion Acquisition of Divvy Homes’ Portfolio and Platform
Latham & Watkins advised Brookfield Asset Management on the transaction, and Wilson Sonsini Goodrich & Rosati advised Divvy Homes. Divvy Homes, a market leader in the...
Bolt Medical’s $900 Million of Acquisition of Boston Scientific
Wilson Sonsini Goodrich & Rosati advised Bolt Medical on the transaction. Boston Scientific (NYSE: BSX) announced it has entered into a definitive agreement to acquire Bolt...
Ceribell’s $53 Million Series C Financing
Wilson Sonsini Goodrich & Rosati advised Ceribell on the deal. Ceribell, innovator of the Rapid Response EEG™, a novel non-invasive brain monitor, announced the completion of...